Reality Check

MMIT Reality Check on Metastatic Prostate Cancer (Dec 2020)

According to our recent payer coverage analysis for metastatic prostate cancer treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense ...
0 Comments

MMIT Reality Check on Type 2 Diabetes (DPP4 and Combo) (Nov 2020)

According to our recent payer coverage analysis for type 2 Diabetes (DPP4 and Combo) treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make ...
0 Comments

MMIT Reality Check on Multiple Myeloma (Nov 2020)

According to our recent payer coverage analysis for multiple myeloma treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this ne...
0 Comments

MMIT Reality Check on Cystic Fibrosis (Nov 2020)

According to our recent payer coverage analysis for cystic fibrosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this new...
0 Comments

MMIT Reality Check on Chronic Lymphocytic Leukemia (Nov 2020)

According to our recent payer coverage analysis for chronic lymphocytic leukemia (CLL) treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help mak...
0 Comments

MMIT Reality Check on Hepatocellular Carcinoma (Oct 2020)

According to our recent payer coverage analysis for hepatocellular carcinoma treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of...
0 Comments

MMIT Reality Check on Psoriasis (Oct 2020)

According to our recent payer coverage analysis for psoriasis (PsO) treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this new...
0 Comments

MMIT Reality Check on Hemophilia A (Factor VIII) (Oct 2020)

According to our recent payer coverage analysis for hemophilia A (factor VIII) treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense ...
0 Comments

MMIT Reality Check on IBS-C (Oct 2020)

According to our recent payer coverage analysis for the treatment of irritable bowel syndrome with constipation (IBS-C), combined with news from key healthcare influencers, market access is shifting in this drug lan...
0 Comments

MMIT Reality Check on Merkel Cell Carcinoma (Oct 2020)

According to our recent payer coverage analysis for Merkel cell carcinoma treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of th...
0 Comments